WEBSITECHANGES

Website Changes

---

10/30/2010

FDA approves Afinitor for brain tumor treatment

---

10/30/2010

IBTA E News October 2010

---

10/29/2010

Targeted therapy for high-grade glioma with the TGF-{beta}2 inhibitor trabedersen: results of a randomized and controlled phase IIb study.

---

10/28/2010

Information on a new form of CED (Convection enhanced delivery) - which allows drugs to bypass the blood brain barrier!

---

10/26/2010

National Brain Tumor Society - Free live Q & A session on ependymoma tumors

---

10/24/2010

Article about the link between viruses (like CMV) and brain tumors.

---

10/24/2010

Oncomodulation by human cytomegalovirus: novel clinical findings open new roads.

---

10/22/2010

NO-54. MODELING TUMOR GROWTH KINETICS AND ITS IMPLICATIONS FOR TTFIELDS TREATMENT PLANNING [Abstracts From SNO 2010]

---

10/22/2010

SUBGROUP AND QUALITY OF LIFE ANALYSES OF THE PHASE III CLINICAL TRIAL OF NOVOTTF-100A VERSUS BEST STANDARD CHEMOTHERAPY FOR RECURRENT GLIOBLASTOMA [Abstracts from SNO]

---

10/22/2010

NO-56. NEW TREATMENT FOR RADIATION NECROSIS OF THE BRAIN

---

10/22/2010

U.S. Blockade Doubly Hurts Cuban Cancer Patients

---

10/22/2010

Abstracts From Society For Neuro-oncology 2010 Annual Meeting!

---

10/22/2010

New Clinical Study for Recurrent Glioblastoma Being Conducted at City of Hope: Neural Stem Cell Platform: First-In-Human Trials

---

10/21/2010

Exiqon subsidiary Oncotech goes out of business — irresponsibly

---

10/20/2010

Brain Tumor Non Profit is a Top Ten Finalist for Charity of the Year [Editor`s Note: This organization was one of the cofounders of the Grey Ribbon Crusade with us - they are a good group and please vote for them!]

---

10/20/2010

Placebos Might Be Potent Enough to Affect Results: Study

---

10/19/2010

Brain tumour vaccine set for trial

---

10/18/2010

Peregrine: brain cancer trial results show promise

---

10/18/2010

BRAINSTORM: A Dialogue and Education Series - Long Branch, NJ Oct 25

---

10/14/2010

Selective cell death mediated by small conditional RNAs

---

10/14/2010

`Keyhole` procedure safer than invasive approaches in removing acoustic neuroma without hearing loss

---

10/13/2010

ImmunoCellular Therapeutics CEO Explains Economic Significance of New Vaccine Manufacturing Method

---

10/12/2010

Single-Arm Phase II Study of Conformal Radiation Therapy and Temozolomide plus Fractionated Stereotactic Conformal Boost in High-Grade Gliomas : Final Report.

---

10/12/2010

The Musella Foundation awarded a $28,000 grant today for the project titled: ~~~Chemoradiotherapy of High Grade Gliomas Using Convection Enhanced Delivery of Carboplatin in Combination with X-irradiation~~~

---

10/12/2010

Advances in Neurology and Neurosurgery Patient Conference November 13, 2010 at The Doubletree Hotel in Bakersfield, CA

---